Study Estimates Post-COVID Risk for Alopecia Areata
The incidence of alopecia areata in patients with COVID-19 was significantly higher than that in the uninfected controls, in a large Korean cohort study.
Source: medscape.com
📰 Immunizations News
Page 9 - Immunizations News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immunizations. Real-time updates on events, politics, business and more.
Shingles Vaccine Offers 4 Years of Protection
Two doses of the recombinant zoster vaccine protect patients for longer than previously known.
United States Rhode Island Nicola Klein Alexandra Tien Us Centers For Disease Associates Of Rhode Island
Source: medscape.com
HPV Vax Tied to Lower Odds of Cervical Lesion Progression
Vaccination status may help clinicians assess the likelihood that cervical intraepithelial neoplasia grade 2 will progress.
United States Louise Krog Aarhus University American Journal Hpv Human Papillomavirus Cervical Cancer
Source: medscape.com
These Are the New Vaccines You Should Get—and It's Not Just Covid-19
The CDC is urging people to get up to date on recommended vaccines
Source: wsj.com
Riverview Gardens School District opens doors to new clinic
The Riverview Gardens School District is making sure students have access to good quality healthcare.
Carestl Health Professionals Riverview Gardens School District Riverview Gardens High School First Alert Riverview Gardens High Riverview Garden School Distrrict
Source: firstalert4.com
Moderna's stock soars after Oppenheimer upgrades to buy
Moderna's stock started the year with a bang thanks to an analyst upgrade.
Source: marketwatch.com
Pfizer and Moderna Covid Vaccines Approved by FDA
This year’s rollout marks a definitive transition to a commercial market for the vaccines, which had previously been purchased by the U.S. government....
Source: marketwatch.com
Moderna Stock Starts 2024 With an Upgrade on Covid-19 Vaccine Outlook
Analysts see Moderna's Covid-19 sales reaching a low point this year and rebounding in 2025 and beyond.
Source: marketwatch.com
Soligenix Shares Rise 19% After Vaccine Trial Shows Protection Against Two Viruses
By Ben Glickman Shares of Soligenix were higher Tuesday after a trial of the company's vaccine candidate showed protection against two viruses. The stock was...
Ben Glickman University Of Hawaii At Manoa Article Normal Biotechnology Services Healthcare Life Sciences Specialized Drugs Medications
Source: marketwatch.com
Moderna's stock soars after Oppenheimer upgrades to buy
Moderna's stock started the year with a bang thanks to an analyst upgrade.
Source: marketwatch.com